Lab21 makes appointment
This article was originally published in Scrip
Executive Summary
Lab21, a UK-based company focused on personalised medicine, has named Susan Lowther chief financial officer. She has more than 20 years' experience in the pharmaceutical, biotech and healthcare industries, having previously held senior management positions at BioWisdom, RiboTargets, Lonza Biologics, Celltech and Monsanto.